Understanding Financial Hardship Among Cancer Survivors in the United States: Strategies for Prevention and Mitigation
Menées dans un contexte américain, ces différentes études abordent les aspects économiques et financiers liés au cancer et à ses traitements, qu'il s'agisse de l'impact de la maladie sur l'emploi des personnes atteintes, des stratégies pour réduire les coûts des médicaments, du coût des programmes de prévention ou de dépistage, des difficultés financières des patients ayant survécu à la maladie, etc.
Cancer survivors spend more out of pocket (OOP) for medical care than their counterparts without a cancer history, a pattern that persists many years after cancer diagnosis and completion of treatment.1 This excess financial burden for patients with cancer, survivors, and their families has continued to grow as the costs of cancer care have increased dramatically in the past decades,2,3 with many new cancer drugs priced at $100,000 or higher annually.4 Furthermore, health insurers are increasingly shifting costs of care to patients through higher deductibles, copayments, and coinsurance.5 Compounding matters is the negative impact of cancer on employment,1,6 resulting in forgone income and loss of employment-sponsored health insurance for some patients. Consequently, patients with cancer and their families experience financial hardship associated with cancer, including problems paying medical bills, distress and worry about medical bills, and delaying or forgoing of medical care because of costs
Journal of Clinical Oncology , résumé, 2018